NCT06707129View on ClinicalTrials.gov

Establishment of Precise Histological Evaluation Criteria for NASH Fibrosis Reversal

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2027

Conditions
Non-alcoholic Fatty Liver Disease
Interventions
OTHER

life-style

The patients were given health education and lifestyle intervention guidance, followed by lifestyle adjustment for at least 1 year and no more than 3 years, and a second liver biopsy was performed to evaluate liver histological changes.

Trial Locations (1)

100015

RECRUITING

Beijing Ditan Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

Beijing Municipal Administration of Hospitals

OTHER_GOV